Skip to main content
. Author manuscript; available in PMC: 2017 Mar 16.
Published in final edited form as: Cancer Gene Ther. 2016 Sep 16;23(10):348–354. doi: 10.1038/cgt.2016.39

Table 2.

Combination indices1 (CI) following dacarbazine and ABT-888 treatment in H727

5µM
ABT-888		 10µM
ABT-888
Dacarbazine(µM) CI
10 2.49 2.59
25 1.32 3.48
50 0.96 1.41
100 1.12 1.19
200 1.22 1.08
300 1.25 1.05
400 1.19 0.96
500 1.25 0.88
750 0.61 0.78
1000 0.54 0.40
1

Calculated based on the Chou-Talalay method (>1:antagonism, =1:additivity, <1:synergy)